FDA Approves CLEOCIN HYDROCHLORIDE — Pharmacia & Upjohn Company LLC
Pharmacia & Upjohn Company LLC announced the approval of the generic form of CLEOCIN HYDROCHLORIDE, establishing a new generic entry that is expected to intensify competitive pressures on brand-name market share. This NDA revamp leverages a 1970 anchor date to maintain market exclusivity, likely driving sales for the company despite broader availability of the drug.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed